244460 — OliPass Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: Olipass To Conduct Capital Increase Of 6.5 Billion Won
Brief: Olipass To Conduct Capital Increase Of 5 Billion Won For Operational Funds
Brief: Vanda Pharmaceuticals And OliPass Announce Strategic Partnership To Develop Antisense Oligonucleotide Therapeutics
Brief: Olipass Corp SCN9A Antisense Pain Killer OLP-1002 Moves Into Phase 2A Stage